ArticleThe Indian journal of medical research2025
Screening for non-alcoholic fatty liver disease (NAFLD) among adults in Puducherry, India: A community-based cross-sectional study.
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives Non-alcoholic fatty liver disease (NAFLD) is an emerging public health issue and affects 20-30 per cent of the general population globally and 9-53 per cent in India. We aimed to estimate the prevalence of NAFLD and associated risk factors among adults at high risk for NAFLD (≥30 yr) in Puducherry. Methods A community-based cross-sectional study was conducted among 350 adults at high risk for NAFLD (simple random sampling) in a rural area of Puducherry. Clinical assessment, and blood investigations (liver function tests, lipid profile) were performed. NAFLD was diagnosed using the fatty liver index and risk stratification for advanced liver fibrosis by using the FIB-4 score. The indeterminate/high-risk participants underwent vibration controlled transient elastography (VCTE). Prevalence of NAFLD [proportions with 95 per cent confidence interval (CI)] and risk factors associated with NAFLD (multivariable regression) were reported. Results Prevalence of NAFLD among adults at high risk was 22.8 per cent (95% CI:18.7% -27.5%); and higher among men (35.2%), those with diabetes mellitus (33.3%) and obesity (40.2%). Male sex, diabetes mellitus and elevated alanine transferase were significantly associated with high risk of NAFLD. Interpretation & conclusions One in four screened adults had NAFLD, increasing to one in two among those with comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.